- Report
- August 2024
- 135 Pages
Global
From €3853EUR$3,899USD£3,207GBP
- Report
- August 2024
- 141 Pages
Global
From €3853EUR$3,899USD£3,207GBP
- Report
- August 2024
- 146 Pages
Global
From €3853EUR$3,899USD£3,207GBP
- Report
- August 2024
- 149 Pages
Global
From €3853EUR$3,899USD£3,207GBP
- Report
- August 2024
- 139 Pages
Global
From €3853EUR$3,899USD£3,207GBP
- Report
- July 2024
- 136 Pages
Global
From €3853EUR$3,899USD£3,207GBP
- Report
- July 2024
- 141 Pages
Global
From €3853EUR$3,899USD£3,207GBP
- Report
- April 2024
- 135 Pages
Global
From €3853EUR$3,899USD£3,207GBP
- Report
- April 2024
- 138 Pages
Global
From €3853EUR$3,899USD£3,207GBP
- Report
- March 2024
- 141 Pages
Global
From €3853EUR$3,899USD£3,207GBP
- Report
- March 2024
- 142 Pages
Global
From €3853EUR$3,899USD£3,207GBP
- Report
- November 2024
- 287 Pages
Global
From €5533EUR$5,600USD£4,605GBP
- Report
- November 2024
- 285 Pages
Global
From €5533EUR$5,600USD£4,605GBP
- Report
- November 2024
- 1417 Pages
Global
From €5731EUR$5,800USD£4,770GBP
- Report
- November 2024
- 803 Pages
Global
From €5533EUR$5,600USD£4,605GBP
- Report
- November 2024
- 89 Pages
Global
From €5533EUR$5,600USD£4,605GBP
- Report
- November 2024
- 166 Pages
Global
From €5385EUR$5,450USD£4,482GBP
- Report
- November 2024
- 179 Pages
Global
From €5385EUR$5,450USD£4,482GBP
- Report
- November 2024
- 171 Pages
Global
From €5385EUR$5,450USD£4,482GBP
- Report
- November 2024
- 171 Pages
Global
From €5385EUR$5,450USD£4,482GBP
The Biotechnology market has been affected by the pandemic in a variety of ways. Companies in the sector have had to adjust their operations to meet the demands of the new environment. Many have shifted their focus to developing treatments and vaccines for the virus, while others have had to pivot their operations to meet the needs of the changing market. Companies have also had to adjust their supply chains to ensure the safety of their products and services.
The pandemic has also had an impact on the financial performance of biotechnology companies. Many have seen their stock prices decline due to the uncertainty of the market. Additionally, the pandemic has caused a decrease in research and development spending, as well as a decrease in venture capital investments.
Notable companies in the biotechnology market include Gilead Sciences, Moderna, Regeneron Pharmaceuticals, and Novavax. These companies have all been involved in the development of treatments and vaccines for the virus. Additionally, they have all seen their stock prices increase due to the pandemic. Show Less Read more